Physician profile
Robert John Tripp
NPI 1073503827
$667.20
in general payments reported to CMS, 2019-2025
13 companies · $26.25 in 2025
The $26.25 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $25.96 · 2021: $31.03 · 2022: $128 · 2024: $198 · 2025: $26.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $143.46 | 2024 | Tisseel |
| Merck Sharp & Dohme LLC | $102.24 | 2019 | |
| Smith+Nephew, INC. | $101.27 | 2019-2022 | |
| Brainlab, INC. | $94.70 | 2019 | |
| Davol INC. | $44.25 | 2022 | |
| Ucb, INC. | $32.92 | 2024 | Cimzia |
| Ethicon US, LLC | $26.25 | 2025 | Harmonic, Enseal, Echelon; Endopath |
| Conmed Corporation | $25.96 | 2020 | |
| Olympus America INC. | $23.76 | 2019 | |
| Tela Bio, INC. | $22.76 | 2022 | |
| Aroa Biosurgery Incorporated | $21.53 | 2024 | |
| Biotissue Holdings INC. | $14.61 | 2021 | |
| Kci USA, INC. | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tripp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.